Cargando…

Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China

Stringent COVID-19 control measures were imposed in Wuhan between January 23 and April 8, 2020. Estimates of the prevalence of infection following the release of restrictions could inform post-lockdown pandemic management. Here, we describe a city-wide SARS-CoV-2 nucleic acid screening programme bet...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Shiyi, Gan, Yong, Wang, Chao, Bachmann, Max, Wei, Shanbo, Gong, Jie, Huang, Yuchai, Wang, Tiantian, Li, Liqing, Lu, Kai, Jiang, Heng, Gong, Yanhong, Xu, Hongbin, Shen, Xin, Tian, Qingfeng, Lv, Chuanzhu, Song, Fujian, Yin, Xiaoxv, Lu, Zuxun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7679396/
https://www.ncbi.nlm.nih.gov/pubmed/33219229
http://dx.doi.org/10.1038/s41467-020-19802-w
_version_ 1783612333359104000
author Cao, Shiyi
Gan, Yong
Wang, Chao
Bachmann, Max
Wei, Shanbo
Gong, Jie
Huang, Yuchai
Wang, Tiantian
Li, Liqing
Lu, Kai
Jiang, Heng
Gong, Yanhong
Xu, Hongbin
Shen, Xin
Tian, Qingfeng
Lv, Chuanzhu
Song, Fujian
Yin, Xiaoxv
Lu, Zuxun
author_facet Cao, Shiyi
Gan, Yong
Wang, Chao
Bachmann, Max
Wei, Shanbo
Gong, Jie
Huang, Yuchai
Wang, Tiantian
Li, Liqing
Lu, Kai
Jiang, Heng
Gong, Yanhong
Xu, Hongbin
Shen, Xin
Tian, Qingfeng
Lv, Chuanzhu
Song, Fujian
Yin, Xiaoxv
Lu, Zuxun
author_sort Cao, Shiyi
collection PubMed
description Stringent COVID-19 control measures were imposed in Wuhan between January 23 and April 8, 2020. Estimates of the prevalence of infection following the release of restrictions could inform post-lockdown pandemic management. Here, we describe a city-wide SARS-CoV-2 nucleic acid screening programme between May 14 and June 1, 2020 in Wuhan. All city residents aged six years or older were eligible and 9,899,828 (92.9%) participated. No new symptomatic cases and 300 asymptomatic cases (detection rate 0.303/10,000, 95% CI 0.270–0.339/10,000) were identified. There were no positive tests amongst 1,174 close contacts of asymptomatic cases. 107 of 34,424 previously recovered COVID-19 patients tested positive again (re-positive rate 0.31%, 95% CI 0.423–0.574%). The prevalence of SARS-CoV-2 infection in Wuhan was therefore very low five to eight weeks after the end of lockdown.
format Online
Article
Text
id pubmed-7679396
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-76793962020-11-24 Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China Cao, Shiyi Gan, Yong Wang, Chao Bachmann, Max Wei, Shanbo Gong, Jie Huang, Yuchai Wang, Tiantian Li, Liqing Lu, Kai Jiang, Heng Gong, Yanhong Xu, Hongbin Shen, Xin Tian, Qingfeng Lv, Chuanzhu Song, Fujian Yin, Xiaoxv Lu, Zuxun Nat Commun Article Stringent COVID-19 control measures were imposed in Wuhan between January 23 and April 8, 2020. Estimates of the prevalence of infection following the release of restrictions could inform post-lockdown pandemic management. Here, we describe a city-wide SARS-CoV-2 nucleic acid screening programme between May 14 and June 1, 2020 in Wuhan. All city residents aged six years or older were eligible and 9,899,828 (92.9%) participated. No new symptomatic cases and 300 asymptomatic cases (detection rate 0.303/10,000, 95% CI 0.270–0.339/10,000) were identified. There were no positive tests amongst 1,174 close contacts of asymptomatic cases. 107 of 34,424 previously recovered COVID-19 patients tested positive again (re-positive rate 0.31%, 95% CI 0.423–0.574%). The prevalence of SARS-CoV-2 infection in Wuhan was therefore very low five to eight weeks after the end of lockdown. Nature Publishing Group UK 2020-11-20 /pmc/articles/PMC7679396/ /pubmed/33219229 http://dx.doi.org/10.1038/s41467-020-19802-w Text en © The Author(s) 2020, corrected publication 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Cao, Shiyi
Gan, Yong
Wang, Chao
Bachmann, Max
Wei, Shanbo
Gong, Jie
Huang, Yuchai
Wang, Tiantian
Li, Liqing
Lu, Kai
Jiang, Heng
Gong, Yanhong
Xu, Hongbin
Shen, Xin
Tian, Qingfeng
Lv, Chuanzhu
Song, Fujian
Yin, Xiaoxv
Lu, Zuxun
Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China
title Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China
title_full Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China
title_fullStr Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China
title_full_unstemmed Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China
title_short Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China
title_sort post-lockdown sars-cov-2 nucleic acid screening in nearly ten million residents of wuhan, china
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7679396/
https://www.ncbi.nlm.nih.gov/pubmed/33219229
http://dx.doi.org/10.1038/s41467-020-19802-w
work_keys_str_mv AT caoshiyi postlockdownsarscov2nucleicacidscreeninginnearlytenmillionresidentsofwuhanchina
AT ganyong postlockdownsarscov2nucleicacidscreeninginnearlytenmillionresidentsofwuhanchina
AT wangchao postlockdownsarscov2nucleicacidscreeninginnearlytenmillionresidentsofwuhanchina
AT bachmannmax postlockdownsarscov2nucleicacidscreeninginnearlytenmillionresidentsofwuhanchina
AT weishanbo postlockdownsarscov2nucleicacidscreeninginnearlytenmillionresidentsofwuhanchina
AT gongjie postlockdownsarscov2nucleicacidscreeninginnearlytenmillionresidentsofwuhanchina
AT huangyuchai postlockdownsarscov2nucleicacidscreeninginnearlytenmillionresidentsofwuhanchina
AT wangtiantian postlockdownsarscov2nucleicacidscreeninginnearlytenmillionresidentsofwuhanchina
AT liliqing postlockdownsarscov2nucleicacidscreeninginnearlytenmillionresidentsofwuhanchina
AT lukai postlockdownsarscov2nucleicacidscreeninginnearlytenmillionresidentsofwuhanchina
AT jiangheng postlockdownsarscov2nucleicacidscreeninginnearlytenmillionresidentsofwuhanchina
AT gongyanhong postlockdownsarscov2nucleicacidscreeninginnearlytenmillionresidentsofwuhanchina
AT xuhongbin postlockdownsarscov2nucleicacidscreeninginnearlytenmillionresidentsofwuhanchina
AT shenxin postlockdownsarscov2nucleicacidscreeninginnearlytenmillionresidentsofwuhanchina
AT tianqingfeng postlockdownsarscov2nucleicacidscreeninginnearlytenmillionresidentsofwuhanchina
AT lvchuanzhu postlockdownsarscov2nucleicacidscreeninginnearlytenmillionresidentsofwuhanchina
AT songfujian postlockdownsarscov2nucleicacidscreeninginnearlytenmillionresidentsofwuhanchina
AT yinxiaoxv postlockdownsarscov2nucleicacidscreeninginnearlytenmillionresidentsofwuhanchina
AT luzuxun postlockdownsarscov2nucleicacidscreeninginnearlytenmillionresidentsofwuhanchina